Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) deposition
- PMID: 20837517
- PMCID: PMC2955133
- DOI: 10.1073/pnas.1010461107
Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) deposition
Abstract
Amyloid-β (Aβ) plaque deposition can precede the clinical manifestations of dementia of the Alzheimer type (DAT) by many years and can be associated with changes in brain metabolism. Both the Aβ plaque deposition and the changes in metabolism appear to be concentrated in the brain's default-mode network. In contrast to prior studies of brain metabolism which viewed brain metabolism from a unitary perspective that equated glucose utilization with oxygen consumption, we here report on regional glucose use apart from that entering oxidative phosphorylation (so-called "aerobic glycolysis"). Using PET, we found that the spatial distribution of aerobic glycolysis in normal young adults correlates spatially with Aβ deposition in individuals with DAT and cognitively normal participants with elevated Aβ, suggesting a possible link between regional aerobic glycolysis in young adulthood and later development of Alzheimer pathology.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Comment in
-
Correlation of brain amyloid with "aerobic glycolysis": A question of assumptions?Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17459-60. doi: 10.1073/pnas.1012684107. Epub 2010 Oct 4. Proc Natl Acad Sci U S A. 2010. PMID: 20921385 Free PMC article. No abstract available.
-
Metabolism: Spotlight on aerobic glycolysis.Nat Rev Neurosci. 2010 Nov;11(11):729. doi: 10.1038/nrn2937. Nat Rev Neurosci. 2010. PMID: 20979317
References
-
- Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science. 2002;297:353–356. - PubMed
-
- Hulette CM, et al. Neuropathological and neuropsychological changes in “normal” aging: Evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol. 1998;57:1168–1174. - PubMed
-
- Morris JC, Price AL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci. 2001;17:101–118. - PubMed
-
- Klunk WE, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306–319. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
